↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

110 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 2-[[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]- n,n,6-trimethyl-4-pyridinecarboxamide,dihydrochloride - - - - 2件:  6 , 162 💬
2 Ac-203 1% topical ointment - - - - 1件: 162 💬
3 Acetate Acetate - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
4 Akst4290 - - - - 2件:  6 , 162 💬
5 Apremilast Apremilast 1件: D08860 💬 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 6件: 46, 50, 56, 97, 162, 271 💬
6 Arava - - - - 2件: 46, 162 💬
7 Avdoralimab Avdoralimab - - - 1件: 162 💬
8 Avdoralimab (iph5401) Avdoralimab - - - 1件: 162 💬
9 Azathioprine Azathioprine 2件: D00238, D03033 💬 - - 20件:  6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬
10 Azathioprine or mycophenolate mofetil Azathioprine 6件: D00238, D00752, D03033, D05094, D05095, D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 1件: 162 💬
11 Benralizumab Benralizumab 1件: D09874 💬 1件: IL5RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 4件: 44, 45, 98, 162 💬
12 Bertilimumab - - - - 2件: 97, 162 💬
13 Biv009 - - - - 2件: 61, 162 💬
14 Blood test - - - - 5件: 36, 86, 113, 162, 299 💬
15 Carboxymethylcellulose Carboxymethylcellulose 1件: D07622 💬 - - 2件: 35, 162 💬
16 Cc - - - - 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬
17 Cc-10004 - - - - 5件: 46, 56, 97, 162, 271 💬
18 Cellcept® in autoimmune bullous dermatoses - - - - 2件: 35, 162 💬
19 Cellulose Microcrystalline cellulose 1件: D00093 💬 - - 4件: 35, 53, 96, 162 💬
20 Clobetasol Clobetasol 1件: D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 4件: 39, 46, 51, 162 💬
21 Clobetasol 0.05% topical ointment Clobetasol 1件: D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
22 Clobetasol propionate Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 46, 162 💬
23 Clobetasol propionate + methotrexate Clobetasol 4件: D00142, D01272, D02115, D07715 💬 3件: DHFR, DHFR2, NR3C1 💬 6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 1件: 162 💬
24 Clobetasol propionate alone Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
25 Clobetasol propionate cream treatment Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
26 Collagenase Collagenase clostridium histolyticum 1件: D09596 💬 - - 1件: 162 💬
27 Cortancyl Prednisone acetate 1件: D08416 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 35, 41, 162 💬
28 Cortancyl 20 mg Prednisone acetate 1件: D08416 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
29 Cotton Cotton - - - 2件: 35, 162 💬
30 Cultivated oral mucosal epithelial sheet transplantation - - - - 2件: 38, 162 💬
31 Cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
32 Cyclophosphamide 50mg oral tablet Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 162 💬
33 Cyclosporine Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬
34 Data report - - - - 1件: 162 💬
35 Dermoval - - - - 2件: 35, 162 💬
36 Device: carboxymethylcellulose with ionic silver (aquacel ag) Carboxymethylcellulose 1件: D07622 💬 - - 2件: 35, 162 💬
37 Device: cellulose acetate with petrolatum Acetate 3件: D00093, D05304, D05331 💬 - - 2件: 35, 162 💬
38 Device: cotton gauze with petrolatum Cotton 2件: D05304, D05331 💬 - - 2件: 35, 162 💬
39 Device: nanocrystalline silver (acticoat) Silver - - - 2件: 35, 162 💬
40 Dexamethasone Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
41 Dexamethasone 0.5mg/5ml solution Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
42 Dexamethasone 0.5mg/5ml solution in mucolox™ Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
43 Df2156a - - - - 1件: 162 💬
44 Doxycycline Doxycycline 5件: D00307, D02129, D03903, D03904, D07876 💬 - - 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬
45 Dupilumab Dupilumab 1件: D10354 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 4件: 51, 98, 160, 162 💬
46 Dupixent - - - - 3件: 98, 160, 162 💬
47 Gold Gold - - - 38件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
48 Halometasone Halometasone 1件: D07202 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
49 Imatinib Imatinib 2件: D01441, D08066 💬 3件: ABL1, KIT, PDGFRA 💬 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
50 Infliximab Infliximab 1件: D02598 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬
51 Interleukin-2 Human interleukin-2 - - - 8件:  2 , 35, 49, 55, 65, 96, 97, 162 💬
52 Iph5401 - - - - 1件: 162 💬
53 Ixekizumab Ixekizumab 1件: D10071 💬 1件: IL17A 💬 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 5件: 36, 37, 162, 269, 271 💬
54 Ladarixin Ladarixin - - - 1件: 162 💬
55 Leflunomide Leflunomide 1件: D00749 💬 1件: DHODH 💬 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬
56 Mabthera - - - - 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
57 Mabthéra - - - - 2件: 35, 162 💬
58 Mathéra - - - - 2件: 35, 162 💬
59 Medrone - - - - 4件: 46, 51, 83, 162 💬
60 Mepolizumab Mepolizumab 1件: D04923 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 4件: 44, 45, 98, 162 💬
61 Mepolizumab (a-il-5 antibody) Mepolizumab 1件: D04923 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 1件: 162 💬
62 Methotrexate Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
63 Methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
64 Minocycline Minocycline 2件: D00850, D05045 💬 - - 13件:  2 ,  6 ,  8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬
65 Mometasone Mometasone 3件: D00690, D03325, D08227 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 98, 162 💬
66 Mometasone furoate Mometasone 3件: D00690, D03325, D08227 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 98, 162 💬
67 Mtx - - - - 12件: 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬
68 Mycophenolate Mycophenolic acid 1件: D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 34件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
69 Mycophenolate mofetil Mycophenolate mofetil 4件: D00752, D05094, D05095, D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 32件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
70 Myfortic - - - - 5件: 49, 66, 162, 222, 228 💬
71 Myfortic 180 mg - - - - 1件: 162 💬
72 Myfortic 180 mg filmtabletten - - - - 1件: 162 💬
73 Nicotinamide Nicotinamide 1件: D00036 💬 - - 6件:  2 ,  6 , 18, 49, 162, 191 💬
74 Nnc0215-0384 - - - - 2件: 46, 162 💬
75 Npb-01 - - - - 3件: 13, 14, 162 💬
76 Omalizumab Omalizumab 1件: D05251 💬 1件: FCER1A 💬 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 7件: 46, 53, 65, 98, 162, 226, 299 💬
77 Oral corticosteroids (ocs) - - - - 1件: 162 💬
78 Otezla - - - - 2件: 56, 162 💬
79 Other: blood sample and cotton skin swabs Cotton - - - 1件: 162 💬
80 Other: control - - - - 8件:  6 , 19, 70, 75, 85, 97, 162, 193 💬
81 Petrolatum Petrolatum 2件: D05304, D05331 💬 - - 3件: 35, 158, 162 💬
82 Prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
83 Prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 47件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
84 Procedure: bone densitometry - - - - 1件: 162 💬
85 Procedure: clobetasol propionate Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
86 Procedure: collagenase Collagenase clostridium histolyticum 1件: D09596 💬 - - 1件: 162 💬
87 Procedure: impedance analysis - - - - 1件: 162 💬
88 Procedure: radiographs of the thoracic and lumbar spine - - - - 1件: 162 💬
89 Qge031 - - - - 1件: 162 💬
90 Restasis - - - - 2件: 53, 162 💬
91 Riboflavin Riboflavin 3件: D00050, D01622, D01913 💬 - - 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬
92 Rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
93 Rituximab 1g iv Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 162 💬
94 Rituximab combined with omalizumab Omalizumab 2件: D02994, D05251 💬 2件: FCER1A, MS4A1 💬 5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 1件: 162 💬
95 Rva576 - - - - 3件: 62, 109, 162 💬
96 Silver Silver - - - 2件: 35, 162 💬
97 Simvastatin Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
98 Simvastatin-ratiopharm Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 162 💬
99 Simvastatin-ratiopharm® Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 162 💬
100 Solu-medrone - - - - 3件: 51, 83, 162 💬
101 Tildrakizumab Tildrakizumab 1件: D10400 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 2件: 162, 271 💬
102 Tildrakizumab prefilled syringe Tildrakizumab 1件: D10400 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 1件: 162 💬
103 Topical infliximab Infliximab 1件: D02598 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 3件: 38, 39, 162 💬
104 Treatment systemic therapy (prednisone) Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
105 Treatment with systemic therapy (doxycycline) Doxycycline 5件: D00307, D02129, D03903, D03904, D07876 💬 - - 1件: 162 💬
106 Treatment with systemic therapy (methotrexate) Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 162 💬
107 Treatment with systemic therapy (prednisone) Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
108 Treatment with topical superpotent corticosteroid therapy - - - - 1件: 162 💬
109 Tripterygium Tripterygium wilfordii whole - - - 8件: 46, 66, 67, 96, 162, 222, 224, 271 💬
110 Ustekinumab Ustekinumab 1件: D09214 💬 3件: IL12A, IL12B, IL23A 💬 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬

先頭へ